We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current KRRO market cap is 35.4M. The company's latest EPS is USD -109.9108 and P/E is -0.44.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.2M | -20.51M | -15.8M | -12.67M | -41.23M |
| Net Income | -17.37M | -19.54M | -10.8M | -11.61M | -39.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 28.95M | 36.98M | 14.07M | 0 | 0 |
| Operating Income | -20.68M | -27.55M | -84.03M | -83M | -84.53M |
| Net Income | -19.8M | -26.51M | -84.69M | -81.58M | -81.17M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 121.24M | 101.5M | 79.38M | 46.35M | 221.66M |
| Total Liabilities | 52.04M | 48.25M | 33.98M | 9.61M | 51.75M |
| Total Equity | 69.2M | 53.25M | 45.41M | 36.74M | 169.91M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 223.22M | 264.72M | 185.36M | 121.24M | 221.66M |
| Total Liabilities | 55.86M | 72.23M | 54.53M | 52.04M | 51.75M |
| Total Equity | 167.36M | 192.49M | 130.82M | 69.2M | 169.91M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -58.24M | -14.13M | -22.56M | -27.36M | -67.28M |
| Investing | 31.13M | 5.5M | 24.71M | 31.53M | 11.16M |
| Financing | -577k | -2.47M | -14.14M | -14.13M | 187.76M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 34.22M | -45.19M | -76.06M | -58.24M | -67.28M |
| Investing | -18.26M | 10.4M | -66.13M | 31.13M | 11.16M |
| Financing | 142.02M | 56.69M | 1.36M | -577k | 187.76M |
| Market Cap | 35.4M |
| Price to Earnings Ratio | -0.44 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.21 |
| Price to Book Ratio | 0.21 |
| Dividend Yield | - |
| Shares Outstanding | 738.53k |
| Average Volume (1 week) | 47.6k |
| Average Volume (1 Month) | 43.7k |
| 52 Week Change | 268.69% |
| 52 Week High | 97.91 |
| 52 Week Low | 13.00 |
| Spread (Intraday) | 3.4 (7.02%) |
| Company Name | Korro Bio Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.korrobio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
